Ignite Creation Date:
2024-05-06 @ 1:57 PM
Last Modification Date:
2024-10-26 @ 1:22 PM
Study NCT ID:
NCT04173585
Status:
COMPLETED
Last Update Posted:
2023-03-27
First Post:
2019-11-20
Brief Title:
TEAM-Trial Targeting Epigenetic Therapy Resistance in AML With Bortezomib
Sponsor:
Organization:
University Hospital Heidelberg